Have a personal or library account? Click to login
Acute “Asteatotic” Dermatitis Induced by Pazopanib and Nivolumab in a Patient with Clear Cell Renal Cell Carcinoma Cover

Acute “Asteatotic” Dermatitis Induced by Pazopanib and Nivolumab in a Patient with Clear Cell Renal Cell Carcinoma

Acta Medica Bulgarica
Volume 56 (2026): Issue s1 (February 2026)
By: S. Ramadan and  P. Vasilev  
Open Access
|Feb 2026

Authors

S. Ramadan

Department of Propedeutics of Internal Diseases, Faculty of Medicine, Medical University – Pleven, Bulgaria

P. Vasilev

preslav.vasilev@abv.bg

Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University – Pleven, Bulgaria
Centre of Competence in Personalized Medicine, 3D and Telemedicine, Robotic Assisted and Minimally Invasive Surgery – “Leonardo da Vinci” – Pleven, Bulgaria
DOI: https://doi.org/10.2478/amb-2026-0010 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Journal RSS Feed
Language: English
Page range: 69 - 73
Submitted on: Apr 4, 2024
|
Accepted on: Jun 24, 2025
|
Published on: Feb 21, 2026
Published by: Medical University - Sofia
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
clear cell renal cell carcinoma,
pazopanib,
nivolumab,
adverse events,
asteatotic dermatitis
Related subjects:
Medicine,
Basic medical science,
Immunology,
Clinical medicine,
Clinical medicine, other

© 2026 S. Ramadan, P. Vasilev, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 56 (2026): Issue s1 (February 2026)Next article